For the Inventor, By the Inventor

Enter assignee name

Columbia, MD, United States of America

Acell, Inc.

USPTO Granted Patents = 41

% Expired Patents = 9.8

EPO Patents = 5

Trademarks = 10

Forward Citations = 1,281

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Clay D Fette (18 out of 31 patents)

Alan R Spievack (15 out of 22 patents)

Rodney W Bosley, Jr (12 out of 24 patents)

4. Abram D Janis (11 out of 17 patents)

5. Robert S Tullius (7 out of 8 patents)

6. Benjamin T Kibalo (6 out of 10 patents)

7. Kimberly Kentner (5 out of 5 patents)

8. Katherine A Stuart (5 out of 5 patents)

9. Thomas W Gilbert (1 out of 9 patents)

10. Stephen Francis Badylak (1 out of 91 patents)

11. Jiayu Tang (1 out of 1 patent)

12. Luai Huleihel (1 out of 2 patents)

13. Nathaniel Remlinger (1 out of 1 patent)

14. Nikhil Niraj Gheewala (1 out of 1 patent)

15. Chandra M Valmikinathan (1 out of 1 patent)

Core Competencies:

Extracellular Matrix

Tissue Graft

Hemostatic Device

Bioactive Gels

Tissue Regeneration

Particulate Tissue Graft

Mechanical Properties

Intestinal Disease

Variable Density

41 patents: Sort by Forward Citations

1. 11992579 - Porous foams derived from extracellular matrix, porous foam ECM medical devices, and methods of use and making thereof (2024-05-28),

2. 11826490 - Extracellular matrix sheet devices with improved mechanical properties and method of making (2023-11-28),

3. 11013829 - Particulate tissue graft with components of differing density and methods of making and using the same (2021-05-25),

4. 11000628 - Particulate tissue graft with components of differing density and methods of making and using the same (2021-05-11),

5. 10898610 - Particulate tissue graft with components of differing density and methods of making and using the same (2021-01-26),

6. 10517994 - Variable density tissue graft composition and methods of making and using the same (2019-12-31),

7. 10092678 - Extracellular matrix for the treatment of intestinal disease and methods thereof (2018-10-09),

8. 9795713 - Methods of manufacturing bioactive gels from extracellular matrix material (2017-10-24),

9. 9764056 - Hemostatic device (2017-09-19),

10. 9579183 - Variable density tissue graft composition and methods of making and using the same (2017-02-28),

11. 9561307 - Particulate tissue graft with components of differing density and methods of making and using the same (2017-02-07),

12. 9480771 - Hemostatic device (2016-11-01),

13. 9474829 - Methods of manufacturing bioactive gels from extracellular matrix material (2016-10-25),

14. 9433701 - Extracellular matrix for the treatment of intestinal disease and methods thereof (2016-09-06),

15. 9404077 - Hemostatic device (2016-08-02),

Acell, Inc., based in Columbia, MD, specializes in advanced regenerative medicine technologies. The company focuses on the development and manufacturing of innovative products that utilize extracellular matrix (ECM) technology. Their offerings include porous foams, bioactive gels, and variable density tissue grafts designed to enhance tissue regeneration and healing. Acell's solutions are particularly relevant in the treatment of intestinal diseases and the creation of hemostatic devices, contributing significantly to the field of tissue engineering and regenerative therapies.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

41 Patents

#9 in Columbia, MD

#98 in Maryland

#8,427 in US

#16,669 in the World

Columbia, MD, United States of America

Acell, Inc.

Forward Citations = 1,281

16 inventors:

Clay D Fette (18 out of 31 patents)

Alan R Spievack (15 out of 22 patents)

Rodney W Bosley, Jr (12 out of 24 patents)

4. Abram D Janis (11 out of 17 patents)

5. Robert S Tullius (7 out of 8 patents)

Please report any incorrect information to [email protected]

Loading…